These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3595839)

  • 1. Synthesis of some 3-hydroxy-5-aminopentanoic acid derivatives.
    Carganico G; Cangiano G; Cozzi P; Lovisolo PP
    Farmaco Sci; 1987 Apr; 42(4):277-84. PubMed ID: 3595839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological profile, and quantitative structure-activity relationship of a series of novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Sit SY; Parker RA; Motoc I; Han W; Balasubramanian N; Catt JD; Brown PJ; Harte WE; Thompson MD; Wright JJ
    J Med Chem; 1990 Nov; 33(11):2982-99. PubMed ID: 2231596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorus-containing inhibitors of HMG-CoA reductase. 1. 4-[(2-arylethyl)hydroxyphosphinyl]-3-hydroxy-butanoic acids: a new class of cell-selective inhibitors of cholesterol biosynthesis.
    Karanewsky DS; Badia MC; Ciosek CP; Robl JA; Sofia MJ; Simpkins LM; DeLange B; Harrity TW; Biller SA; Gordon EM
    J Med Chem; 1990 Nov; 33(11):2952-6. PubMed ID: 2231594
    [No Abstract]   [Full Text] [Related]  

  • 4. Alteration of cholesterol synthesis in rat liver as induced by 4-methyl-5-hydroxy valeric acid.
    Díaz-Zagoya JC; Hurtado ME; González J
    Experientia; 1976 Sep; 32(9):1138-40. PubMed ID: 971744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of new HMG-CoA reductase inhibitors. 3. Lactones of 6-phenoxy-3,5-dihydroxyhexanoic acids.
    Jendralla H; Granzer E; von Kerekjarto B; Krause R; Schacht U; Baader E; Bartmann W; Beck G; Bergmann A; Kesseler K
    J Med Chem; 1991 Oct; 34(10):2962-83. PubMed ID: 1656041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent.
    Amin D; Gustafson SK; Weinacht JM; Cornell SA; Neuenschwander K; Kosmider B; Scotese AC; Regan JR; Perrone MH
    Pharmacology; 1993; 46(1):13-22. PubMed ID: 8434028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W; Infante J; Wang SR; Infante R
    Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some effects of chitosan on liver function in the rat.
    LeHoux JG; Grondin F
    Endocrinology; 1993 Mar; 132(3):1078-84. PubMed ID: 7679967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of cholesterol biosynthesis. 2. Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydronaphthalene analogues of the tocotrienols.
    Pearce BC; Parker RA; Deason ME; Dischino DD; Gillespie E; Qureshi AA; Volk K; Wright JJ
    J Med Chem; 1994 Feb; 37(4):526-41. PubMed ID: 8120870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cinnamate supplementation enhances hepatic lipid metabolism and antioxidant defense systems in high cholesterol-fed rats.
    Lee JS; Jeon SM; Park EM; Huh TL; Kwon OS; Lee MK; Choi MS
    J Med Food; 2003; 6(3):183-91. PubMed ID: 14585184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of new HMG-CoA reductase inhibitors. 2. Derivatives of 7-(1H-pyrrol-3-yl)-substituted-3,5-dihydroxyhept-6(E)-enoic (-heptanoic) acids.
    Jendralla H; Baader E; Bartmann W; Beck G; Bergmann A; Granzer E; von Kerekjarto B; Kesseler K; Krause R; Schubert W
    J Med Chem; 1990 Jan; 33(1):61-70. PubMed ID: 2153213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
    Keller RK; Zhao Z; Chambers C; Ness GC
    Arch Biochem Biophys; 1996 Apr; 328(2):324-30. PubMed ID: 8645011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
    Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
    N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. 7. Modification of the hexahydronaphthalene moiety of simvastatin: 5-oxygenated and 5-oxa derivatives.
    Duggan ME; Alberts AW; Bostedor R; Chao YS; Germershausen JI; Gilfillan JL; Halczenko W; Hartman GD; Hunt V; Imagire JS
    J Med Chem; 1991 Aug; 34(8):2489-95. PubMed ID: 1875346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of cholesterol biosynthesis. 2. 3,5-Dihydroxy-7-(N-pyrrolyl)-6-heptenoates, a novel series of HMG-CoA reductase inhibitors.
    Procopiou PA; Draper CD; Hutson JL; Inglis GG; Ross BC; Watson NS
    J Med Chem; 1993 Nov; 36(23):3658-62. PubMed ID: 8246234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes.
    Masters BA; Palmoski MJ; Flint OP; Gregg RE; Wang-Iverson D; Durham SK
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):163-74. PubMed ID: 7878672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Alkyl-3-hydroxyglutaric acids: a new class of hypocholesterolemic HMG CoA reductase inhibitors. 1.
    Baran JS; Laos I; Langford DD; Miller JE; Jett C; Taite B; Rohrbacher E
    J Med Chem; 1985 May; 28(5):597-601. PubMed ID: 3989819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 3-hydroxy-3-cyclohexylbutyric acid derivatives. 2. Cyclic analogues of mevalonic acid.
    Carganico G; Cozzi P; Orsini G
    J Med Chem; 1983 Dec; 26(12):1767-9. PubMed ID: 6644746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mevalonic acid analogs as inhibitors of cholesterol biosynthesis.
    DeBold CR; Elwood JC
    J Pharm Sci; 1981 Sep; 70(9):1007-10. PubMed ID: 6101142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of competitive inhibitors of HMG-CoA reductase.
    Corsini A; Maggi FM; Catapano AL
    Pharmacol Res; 1995 Jan; 31(1):9-27. PubMed ID: 7784310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.